Skip to main content
Top
Published in: Dermatology and Therapy 1/2017

Open Access 01-03-2017 | Case Report

A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes

Authors: Claudia Pföhler, Michael Klotz, Thomas Wehler, Thomas Vogt, Cornelia S. L. Müller

Published in: Dermatology and Therapy | Issue 1/2017

Login to get access

Abstract

Tuberculosis is a worldwide occurring disease that affects approximately 20–40% of the world’s population and in particular in developing countries. However, in times of migration, industrialised countries are again being more and more affected. Cutaneous tuberculosis is rare and lupus vulgaris represents its most common form. Preferentially, young adults in developing or low-income countries are affected from cutaneous tuberculosis, which usually occurs in previously sensitized persons with a high degree of tuberculin sensitivity and a good immunoresponse. In Europe, more elderly people are involved. We present a case of lupus vulgaris that was diagnosed with a delay of about 20 years after onset of first skin changes.
Literature
2.
go back to reference van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015;95(6):629–38.CrossRefPubMed van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015;95(6):629–38.CrossRefPubMed
3.
go back to reference Walker SL, Lozewicz S, Sood R, Mann TA, Campalani E, Hubbard VG. Lupus vulgaris due to Mycobacterium bovis bacillus Calmette–Guerin (BCG) at the site of previous BCG vaccination. Clin Exp Dermatol. 2009;34(7):e213–5.CrossRefPubMed Walker SL, Lozewicz S, Sood R, Mann TA, Campalani E, Hubbard VG. Lupus vulgaris due to Mycobacterium bovis bacillus Calmette–Guerin (BCG) at the site of previous BCG vaccination. Clin Exp Dermatol. 2009;34(7):e213–5.CrossRefPubMed
4.
go back to reference Tar SY, Bozdemir B, Gurel MS, Bilgin FU, Baran MF, Demirkesen C. Mycobacterium bovis caprae: a rare agent of lupus vulgaris. Clin Exp Dermatol. 2009;34(4):532–3.CrossRefPubMed Tar SY, Bozdemir B, Gurel MS, Bilgin FU, Baran MF, Demirkesen C. Mycobacterium bovis caprae: a rare agent of lupus vulgaris. Clin Exp Dermatol. 2009;34(4):532–3.CrossRefPubMed
5.
go back to reference Meyer S, Naumann L, Landthaler M, Vogt T. Lupus vulgaris caused by Mycobacterium bovis ssp. caprae. Br J Dermatol. 2005;153(1):220–2.CrossRefPubMed Meyer S, Naumann L, Landthaler M, Vogt T. Lupus vulgaris caused by Mycobacterium bovis ssp. caprae. Br J Dermatol. 2005;153(1):220–2.CrossRefPubMed
6.
go back to reference Marchetti G, Gori A, Catozzi L, Vago L, Nebuloni M, Rossi MC, et al. Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues: comparison of four amplification assays. J Clin Microbiol. 1998;36(6):1512–7.PubMedPubMedCentral Marchetti G, Gori A, Catozzi L, Vago L, Nebuloni M, Rossi MC, et al. Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues: comparison of four amplification assays. J Clin Microbiol. 1998;36(6):1512–7.PubMedPubMedCentral
7.
go back to reference Choi JC, Jarlsberg LG, Grinsdale JA, Osmond DH, Higashi J, Hopewell PC, et al. Reduced sensitivity of the QuantiFERON((R)) test in diabetic patients with smear-negative tuberculosis. Int J Tuberc Lung Dis. 2015;19(5):582–8.CrossRefPubMed Choi JC, Jarlsberg LG, Grinsdale JA, Osmond DH, Higashi J, Hopewell PC, et al. Reduced sensitivity of the QuantiFERON((R)) test in diabetic patients with smear-negative tuberculosis. Int J Tuberc Lung Dis. 2015;19(5):582–8.CrossRefPubMed
8.
go back to reference Abdelmalek R, Mebazaa A, Berriche A, Kilani B, Ben Osman A, Mokni M, et al. Cutaneous tuberculosis in Tunisia. Med Mal Infect. 2013;43(9):374–8.CrossRefPubMed Abdelmalek R, Mebazaa A, Berriche A, Kilani B, Ben Osman A, Mokni M, et al. Cutaneous tuberculosis in Tunisia. Med Mal Infect. 2013;43(9):374–8.CrossRefPubMed
9.
go back to reference Bua A, Cubeddu M, Piras D, Delogu R, Zanetti S, Molicotti P. Tuberculosis screening among asylum seekers in Sardinia. J Public Health (Oxf). 2016. doi:10.1093/pubmed/fdv215. Bua A, Cubeddu M, Piras D, Delogu R, Zanetti S, Molicotti P. Tuberculosis screening among asylum seekers in Sardinia. J Public Health (Oxf). 2016. doi:10.​1093/​pubmed/​fdv215.
10.
go back to reference Ibrahim KM, Khan S, Laaser U. Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries. J Ayub Med Coll Abbottabad. 2002;14(4):11–5.PubMed Ibrahim KM, Khan S, Laaser U. Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries. J Ayub Med Coll Abbottabad. 2002;14(4):11–5.PubMed
11.
go back to reference Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016;14:48.CrossRefPubMedPubMedCentral Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016;14:48.CrossRefPubMedPubMedCentral
Metadata
Title
A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes
Authors
Claudia Pföhler
Michael Klotz
Thomas Wehler
Thomas Vogt
Cornelia S. L. Müller
Publication date
01-03-2017
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2017
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-016-0158-x

Other articles of this Issue 1/2017

Dermatology and Therapy 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.